01
Emerging biotech companies
Clinical-stage teams preparing for partner, CRO, investor, or vendor conversations.
Commercial strategy and partnerships for the life sciences ecosystem.
CARAPO Consulting helps biotech, CRO, AI, and clinical technology companies sharpen their positioning, build strategic partnerships, and create early commercial traction across the life sciences ecosystem.
Biotech commercializationCRO business developmentFundraising & partner narrativesStrategic partnerships
Who I help
Focused support for companies building, selling, or partnering across the life sciences ecosystem. From biotech and CROs to AI, software, and clinical technology platforms entering the market.
02
Specialized CROs & service providers
Companies looking to sharpen sponsor-facing positioning, BD strategy, and partnership development.
03
AI & clinical technology platforms
Software, data, or workflow companies selling into biotech, pharma, CRO, or clinical development teams.
04
New entrants to life sciences
Tech-enabled companies that need help understanding buyers, workflows, adoption barriers, and partnership paths.
What I do
Commercial strategy, partnership development, and selective BD support for companies operating in biotech, CRO, AI, and clinical technology—including fundraising narratives, partnering strategy, and licensing readiness.
01
Commercial Strategy & GTM
ICP definition, buyer mapping, market positioning, launch planning, and commercial narrative development.
02
Strategic Partnerships
Biotech, CRO, pharma, and clinical development ecosystem mapping and partnership strategy.
03
Fractional BD Support
Targeted outreach, conference strategy, account prioritization, and early pipeline building.
04
Fundraising, IP & Licensing Positioning
Investor-facing narrative development, IP and differentiation framing, licensing story support, and partner-ready positioning for technical teams entering commercial conversations.
From scientific promise to market adoption.
Operator-led support for companies that need sharper commercial strategy, stronger positioning, and preparation for partner conversations.
Why CARAPO
CRO BD experienceFundraising & licensing strategy supportAI-enabled drug developmentPartnership strategy
CARAPO Consulting is led by Eduardo Aponte, a biotech commercialization operator with experience across CRO business development, fundraising and licensing strategy support, and AI-enabled drug development platforms.
Eduardo has worked across biotech, CROs, and emerging platform companies, supporting market positioning, partnership development, and multi-million-dollar partnership and commercialization opportunities.
The goal is simple: help scientific, technical, and service-driven companies translate complex value into commercial traction across the life sciences market.
Let’s build the commercial bridge.
For selective consulting, partnership, or commercial strategy support, submit a focused inquiry below.